Simultaneous early ovarian and endometrial cancer treated conservatively with spontaneous pregnancy

Journal of Ovarian Research

Georges Chahine²  Roman Rouzier³  Nadine el Kassis¹  Joelle Safi¹  David Atallah¹ 

[1] Obstetrics and Gynecology, Hôtel Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon;Medical Oncology, Hôtel Dieu de France University Hospital, Saint Joseph University, Beirut, Lebanon;Institut Curie comprehensive cancer center, Paris, France

关键词: Synchronous;    Pregnancy;    Ovarian cancer;    Endometrial;    Conservative treatment;   

Others  :  805913
DOI  :  10.1186/1757-2215-6-59

 received in 2013-07-07, accepted in 2013-08-20,  发布年份 2013

【 摘 要 】

Introduction

Young cancer patients increasingly request fertility sparing alternatives to their cancer treatments, which they should be offered when allowed so by the risk-benefit balance and after obtaining informed consent.

Case presentation

Here, we report the case of a 25 year-old nulliparous patient who presented with a synchronous endometrioid ovarian and endometrial carcinoma. She was able to conduct a full-term spontaneous pregnancy after conservative surgical treatment followed by adjuvant chemotherapy and hormonal treatment. Fertility sparing treatment is feasible in selected cases of synchronous ovarian and endometrial cancers. Thorough follow-up remains mandatory.

Conclusion

This case demonstrates some interesting and unique features of synchronous ovarian and endometrial cancers since it resulted in a spontaneous pregnancy and normal delivery.

【 授权许可】

   
2013 Atallah et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Fotopoulou C, Braicu I, Sehouli J: Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: a viable option?. 2012. [S.l. : Hindawi Publishing Corporation] Obstet Gynecol Int 2012, Article ID 238061, 8 pages
• [2]Nam JH, Park JY: Fertility-sparing surgery for young women with early-stage epithelial ovarian cancer. Gynecol Obstet Invest 2013, 76(1):14-24.
• [3]Gershenson DM: Fertility-sparing surgery for malignancies in women. J Natl Cancer Inst Monogr 2005, 34:43-47.
• [4]Chiva L, Lapuente F, González-Cortijo L, Carballo L, García JF, Rojo A, Gonzalez-Martín A: Sparing fertility in young patients with endometrial cancer. Gynecol Oncol 2008, 111(Suppl 2):S101-S104.
• [5]Williams MG, Bandera EV, Demissie K, Rodríguez-Rodríguez L: Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival. Obstet Gynecol 2009, 113(4):783-789.
• [6]Herrinton LJ, Voigt LF, Weiss NS, Beresford SA, Wingo PA: Risk factors for synchronous primary endometrial and ovarian cancers. Ann Epidemiol 2001, 11(8):529-533.
• [7]Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE: Simultaneously detected endometrial and ovarian carcinomas- a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol 2001, 83:355-362.
• [8]Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I: Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 2005, 106(4):693-699.
• [9]Signorelli M, Fruscio R, Lissoni AA, Pirovano C, Perego P, Mangioni C: Synchronous early-stage endometrial and ovarian cancer. Int J Gynaecol Obstet 2008, 102(1):34-38.
• [10]Navarria I, Usel M, Rapiti E, Neyroud-Caspar I, Pelte MF, Bouchardy C, Petignat P: Young patients with endometrial cancer: How many could be eligible for fertility-sparing treatment. Gynecol Oncology 2009, 114(3):448-451.
• [11]American College of Obstetricians and Gynecologists: ACOG practice bulletin: management of adnexal masses. Obstet Gynecol 2007, 110(1):201-214.
• [12]Aebi S, Castiglione M: Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008, 19(Suppl 2):ii14-ii16.
• [13]Kashima K, Yahata T, Fujita K, Tanaka K: Outcomes of fertility-sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer. Int J Gynaecol Obstet 2013, 121(1):53-55.
• [14]Zanetta G, Chiari S, Rota S, Bratina G, Maneo A, Torri V, Mangioni C: Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 1997, 104(9):1030-1035.
• [15]Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ, Modesitt SC, Lu KH, Geisler JP, Higgins RV, Magtibay PM, Cohn DE, Powell MA, Chu C, Stehman FB, van Nagell J: Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 2002, 87(1):1-7.
• [16]Morice P, Leblanc E, Rey A, Baron M, Querleu D, Blanchot J, Duvillard P, Lhommé C, Castaigne D, Classe JM, Bonnier P, GCCLCC and SFOG: Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d’Oncologie Gynécologique). Hum Reprod 2005, 20(5):1379-1385.
• [17]Borgfeldt C, Iosif C, Måsbäck A: Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007, 134(1):110-114.
• [18]Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH: Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol 2008, 110(3):345-353.
• [19]Kajiyama H, Shibata K, Suzuki S, Ino K, Nawa A, Kawai M, Nagasaka T, Kikkawa F: Fertility-sparing surgery in young women with invasive epithelial ovarian cancer. Eur J Surg Oncol 2010, 36(4):404-408.
• [20]Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, Yamaguchi S, Ochiai K, Takano M, Yokota H, Kawakami Y, Nishimura S, Ogishima D, Nakagawa S, Kobayashi H, Shiozawa T, Nakanishi T, Kamura T, Konishi I, Yoshikawa H: Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol 2010, 28(10):1727-1732.
• [21]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines 2012). [Uterine Neoplasms] [http://www.tri-kobe.org/nccn/guideline/gynecological/english/uterine.pdf webcite]
• [22]Martinez A, Poilblanc M, Ferron G, De Cuypere M, Jouve E, Querleu D: Fertility-preserving surgical procedures, techniques. Best Pract Res Clin Obstet Gynaecol 2012, 26(3):407-424.
• [23]American College of Obstetricians and Gynecologists: ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005, 106(2):413-425.
• [24]Hahn HS, Yoon SG, Hong JS, Hong SR, Park SJ, Lim JY, Kwon YS, Lee IH, Lim KT, Lee KH, Shim JU, Mok JE, Kim TJ: Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer 2009, 19(6):1068-1073.
• [25]Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, Hatae M, Kodama S, Saito T, Terakawa N, Yaegashi N, Hiura M, Sakamoto A, Tsuda H, Fukunaga M, Kamura T: Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 2007, 25(19):2798-2803.
• [26]Laurelli G, Di Vagno G, Scaffa C, Losito S, Del Giudice M, Greggi S: Conservative treatment of early endometrial cancer: preliminary results of a pilot study. Gynecol Oncol 2011, 120(1):43-46.
• [27]Mazzon I, Corrado G, Masciullo V, Morricone D, Ferrandina G, Scambia G: Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril 2010, 93(4):1286-1289.
• [28]Colombo N, Guthrie D, Chiari S, Parmar M, Qian W, Swart AM, Torri V, Williams C, Lissoni A, Bonazzi C, International Collaborative Ovarian Neoplasm (ICON) collaborators: International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003, 95(2):125-132.